Histidine-Tryptophan-Ketoglutarate (HTK) and University of Wisconsin (UW) solutions are the 2 primary preservation solutions most commonly used during deceased donor organ procurement in the United States (>95%). These 2 solutions are associated with similar clinical outcomes in all randomized trials previously published for kidney, liver, and pancreas transplantation. For this reason, the 2 solutions are often used interchangeably in clinical practice despite marked differences in fluid composition, viscosity, and recommended flush volume. This webinar analyzes all procurements at a single US organ procurement organization (OPO) to determine the current practice of clinical use of HTK and UW, including vessels flushed and flush volume. The speaker will specifically examine each preservation solution usage for liver and pancreas grafts, as these are the 2 organs that appear to be most sensitive to variations in preservation solution, volume, and surgical approach.  

We look forward to your participation!

Your Köhler Campus team

About the Event

The Speaker

Registration

This event is targeted at physicians, pharmacists and healthcare professionals and is free of charge.
Register to receive the link to the live webinar using the form below.